Free Trial
→ “This Changes Everything” - Trump Hands Millions Massive IRS Gift (From Colonial Metals) (Ad) Free PTGX Stock Alerts

Protagonist Therapeutics (PTGX) SEC Filings & 10K Form

Protagonist Therapeutics logo
$41.11 +0.07 (+0.17%)
(As of 11/15/2024 ET)
Compare

Recent Protagonist Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
11/14/2024
3:27 PM		BIOTECHNOLOGY VALUE FUND L P (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
11/12/2024
3:51 PM		Protagonist Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/07/2024
3:39 PM		Protagonist Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
12:22 PM		Protagonist Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/16/2024
11:48 AM		Protagonist Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
09/13/2024
3:35 PM		Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
6:38 PM		Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
5:15 PM		Ali Asif (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2024
3:17 PM		Protagonist Therapeutics (Subject)
Waddill William D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/06/2024
3:18 PM		Protagonist Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2024
6:08 AM		Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
3:31 PM		Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
3:33 PM		Protagonist Therapeutics (Subject)
Waddill William D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2024
3:12 PM		Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
3:30 PM		PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:30 PM		PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:30 PM		Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:46 PM		Protagonist Therapeutics (Subject)
Waddill William D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2024
3:51 PM		Protagonist Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/19/2024
7:05 PM		Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2024
3:30 PM		Protagonist Therapeutics (Filer)
Form PRE 14A
04/02/2024
7:29 PM		PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:00 PM		Protagonist Therapeutics (Issuer)
SELICK HAROLD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
7:45 PM		Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
7:45 PM		Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
7:46 PM		PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
7:27 PM		Ali Asif (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
3:32 PM		Protagonist Therapeutics (Subject)
Waddill William D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
4:48 PM		Ali Asif (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
7:00 PM		Gupta Suneel (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
7:02 PM		PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
3:33 PM		Protagonist Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2024
7:00 PM		PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
8:31 AM		BIOTECHNOLOGY VALUE FUND L P (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
02/14/2024
6:47 AM		Protagonist Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
02/14/2024
6:15 AM		Point72 Asset Management, L.P. (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
02/13/2024
4:12 PM		Protagonist Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/07/2024
6:41 AM		ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
02/02/2024
8:19 AM		Farallon Capital Partners, L.P. (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
01/24/2024
1:27 PM		BlackRock Inc. (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
01/23/2024
9:55 AM		Protagonist Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
5 Stocks that could triple in a week (Ad)

Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942%, and 12,592% in 2020. Now their next one could be here.

Click here to pay just $5 for a full year of Stealth Trades
01/18/2024
7:00 PM		Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
7:00 PM		MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
7:01 AM		Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2024
7:00 PM		Gupta Suneel (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
4:25 PM		Gupta Suneel (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
7:00 AM		Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
7:17 PM		Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:07 PM		Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:09 PM		MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:10 PM		Giraudo Bryan (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:11 PM		PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:13 PM		Protagonist Therapeutics (Issuer)
SELICK HAROLD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:14 PM		Protagonist Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:15 PM		Gupta Suneel (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:17 PM		O'Dowd Sarah A (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
3:15 PM		Point72 Asset Management, L.P. (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G
12/15/2023
3:30 PM		PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
4:18 PM		PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:PTGX) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners
Bill Gates’s Next Big AI Bet: Stargate
In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...
Brownstone Research | Sponsored
There is a little known company that is changing warfare
With geo - political instability around the world investors are flocking to defense contract stocks. There...
Reticulate | Sponsored
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
24/7 Automated Profits in Crypto
What if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...
Crypto Swap Profits | Sponsored
Trump Wins… But Elon Says Get Ready to Brace
Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...
Genesis Gold Group | Sponsored
Unveiled: NVIDIA’s "Secret Royalty" Program
Did you know that there's an investment that will give you the opportunity to collect "royalties" every time N...
Behind the Markets | Sponsored
Musk’s new company could top a trillion?
The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...
Paradigm Press | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored